OneVentures

Through cutting-edge AI investments and strategic partnerships, we empower the disruptors who are reshaping industries and redefining the future. Our investment strategy is centred on identifying and empowering AI-driven companies that have the vision, proprietary data, and deep expertise to disrupt their industries. We offer flexible SPV structures, providing founders with tailored capital solutions to accelerate their growth. WHAT WE DOINVESTING IN AI-FUELED DISRUPTORS: Seek out and invest in the companies building tomorrow’s intelligent systems - AI-driven platforms that will disrupt industries like education, healthcare, gaming, and robotics. Our focus is on those who harness proprietary data to create transformative solutions. PARTNERSHIP BEYOND CAPITAL: Through our sister company, Kalea Advisors, we don’t just provide capital; we offer deep strategic guidance, cross-border business development, and access to future funding. We partner with our founders to ensure they become tomorrow’s global champions. GLOBAL EXPANSION & STRATEGIC ACCESS: With teams in London, the US, Hong Kong, and Japan, we enable companies to access markets across continents, leveraging our unique global footprint to create synergies between Western and Asian markets. We help AI-driven disruptors scale effectively and lead their industries globally.

Pléiade Venture est une Société de Capital Risque Française. Elle investit sur le long terme, sans horizon de sortie prédéterminé. Elle soutient les entreprises innovantes de tous secteurs, hors biotech. Elle dispose de plus de 100 M€ d'actifs et investit de 0,5 à 3 M€ par opération. Elle est financée par des entrepreneurs qui forts de leur expérience désirent contribuer activement à de nouveaux succès. Elle est animée par une équipe en liaison étroite avec une vingtaine d’entrepreneurs contributifs. Nos différencesEvergreen: Pléiade Venture, à la différence des fonds, investit ses fonds propres et réinvestit ses plus-values, sans horizon de sortie prédéterminé. Actionnaire stable et pérenne, Pléiade Venture s’adapte au projet long terme de l’entrepreneur. Contributif: Notre capital est constitué d'entrepreneurs issus de secteurs variés. Ils réinvestissent une partie de leur patrimoine et partagent leur expérience avec les dirigeants de nos participations. Un quart de nos actionnaires sont d’ailleurs les fondateurs d'entreprises que nous avons financées. Galaxie: Pléiade Venture s’inscrit dans un ensemble de structures indépendantes : Pléiade Investissement (Capital Développement, LBO et retournement) Pléiade AM (Fonds d'actions cotées) autour d’une idée commune : « Faire ensemble, et faire autrement, ce que nous ne ferions pas seuls ! ». Nos CritèresStade: Seed, Series A Secteurs: Tous sauf : Biotechnologies, Entertainment, Immobilier Montant: 0,5 M€ à 3 M€, Seul ou en coinvestissement

As a spin-off and strategic partner of PhotonDelta, the European hub for the integrated photonics industry, we have in-house expertise that gives us a thorough understanding of the industry's success drivers and value inflection points. This allows us to identify and invest capital, time, and network into Europe’s best integrated photonics companies. Why integrated Photonics? Our world markets are in a digital transformation, which results in the progressive growth of data and energy consumption. Integrated Photonics harnesses the unique properties of light to overcome the limitations of traditional electronics-based applications. Integrated photonics technology enables a sustainable digital future by facilitating more compact, high-speed, and energy-efficient transport of data and systems. The diverse sectors harnessing these technologies include Data & Telecom, Medical & Healthcare, Engineering & Transport, and Quantum Computing, with many more cutting-edge applications on the horizon. What we do We invest in companies through their development, scaling, and exit phases. We connect entrepreneurs, investors, executives, engineers, academics, and industry experts across Europe’s Integrated Photonics industry to help our portfolio companies catalyze their success, enabling them to outpace their competitors. We support sustainable, innovative technologies that have the potential to serve a global market, solve complex challenges, and transform industries. Our Vision As global markets undergo transformation due to intensive digitization, and as the pace of Moore's Law slows down, the relevance of integrated photonics technology becomes evident in sectors like data management, communication, sensing, medical diagnosis, and quantum computing. In these fields, high-end solutions rely on the advancements of integrated photonics. At PhotonVentures, our ambition is to develop integrated photonics technology to promote sustainability, inclusivity, and global connectivity. We achieve this by investing in innovative, differentiated companies that use integrated photonics in ways that create economic value and meaningfully impact our world. We provide our portfolio companies with the capital, industry connectivity, and hands-on support they need to succeed, driving the development and dissemination of integrated photonics technologies and applications across Europe and beyond. Our Mission Those who create breakthrough ideas the fastest will generate new markets, exponential financial returns, and a better future for us all. At PhotonVentures, we create economic value with investments in innovative, differentiating deep-tech companies that can rapidly address a large global market, impact society, and maintain a strong, unique, and defensible technology position in integrated photonics. Deep tech, and more specifically integrated photonics, has the potential to significantly improve our world. We support technologies that we believe will have a long-term impact through their innovation and sustainable technology. Our Story PhotonVentures is a deep-tech venture capital firm, purely focused on the key enabling technology of Integrated Photonics. PhotonVentures historically emerged from PhotonDelta, a pioneering force behind the European Integrated Photonics ecosystem. PhotonVentures is fortuned to be an independent strategic partner of PhotonDelta. Founded in 2014, PhotonDelta has driven the growth of the Dutch Integrated Photonics industry, making significant investments in companies and R&D over the past five years. In April 2022, PhotonDelta received €1,1B in public funds from the Dutch National Growth Fund to help propel Integrated Photonics into volume markets. The strategic partnership between PhotonVentures and PhotonDelta lays an even stronger foundation for success.

K2HV’s investment professionals bring together substantial experience across multiple verticals in healthcare finance and operations, as well as considerable scientific knowledge. Our diverse backgrounds and experience give us a deep understanding of the needs of innovative healthcare companies throughout their lifecycles, and underpin our innovative and creative approach to investing. Our leadership team has committed more than $4 billion to over 100 private and public companies in the life sciences and healthcare industries. High Impact Investments, Long-Term ViewUniquely flexible, permanent capital structure enables us to provide long-term financing solutions and meet the evolving capital needs of growing companies Broad investment mandate allows us to be creative with financing structures Primary focus on customized debt financings, but able to invest in equity as well

Trinity Innovation Bioventure Singapore is a licensed biomed venture capital fund focusing on innovation and value investment with deep insight and experience on Asia markets. We are part of the Trinity Innovation Fund group, founded in 2018, managing multiple VC funds in the region. We are an experienced team led by industrial veterans who have managed multiple VC funds and invested over dozens of biotech companies. Our StrengthAccess to China market through synergy with TIF: Two organizations, One Team Multi-dimensional value-added post investment to enhance possibility of success and returns Clear investment thesis: In Asia, for Global; Leverage regional synergy and realize future value Best-in-class team in biomed investment with strong track record Our Focus TIBS seeks to invest and build great companies that emerging biotechnology leads to innovative therapeutics to address global unmet medical needs. We focus on incubating and growing potential early-stage biotech start-ups with breakthrough platform technology, differentiated scientific merit and commercial value. Our Core CompetencyValue Discovery: Select investment projects based on precise judgements from in-depth research Project Incubation: Incubate cutting-edge science or outstanding entrepreneurs with innovative approaches. Unique incubation strategy: project management by investment team to increase the asset value; management team recruitment to maximize the equity value and capital efficiency Help entrepreneurs to grow rapidly with proprietary foresight, industry understanding and resources

We are at the forefront of revolutionary technologies disrupting industries and transforming human life at an accelerating pace towards singularity. Like the high-performance racing teams of Formula 1, we compete to lead premier investments in the world's most exceptional unicorns - hence «Frontline One»